the serum specimen allows subsequent assay of the antibiotic being monitored. This report gives details of a simple procedure for laboratory production of a crude enzyme capable of degrading cephalosporins or penicillins. An assay procedure for quantitating aminoglycosidic or polymyxin antibiotics after enzymatic degradation of a coexisting $-la tam antibiotic is described.
Antibiotic combinations that show additive or synergistic activity are sometimes used for the treatment of serious bacterial infections. 3 Although an assay method for the rapid estimation of singly administered antibiotics in human sera has been reported (7), methodology related -to cephalosporins in combination with other types of antibiotics has not been described. The present investigation proposes tube, were placed on seeded agar assay plates con-to contain 0.5% NaCl. The 6-ml B. bronchiseptica taining Sarcina lutea PCI-1001-FDA. (See prepara-plates, poured as described above for B. subtilis, tion of assay plates, discussed below.) Additional re-were stored at 4 C and used within 2 days. action between residual antibiotic and fl-lactamase Activity of cephalosporin antibiotics used in the after 1 hr was interrupted by adsorption of the enzyme potency assay of EP was detected by use of plates on the paper discs (1), allowing only the remaining seeded with Sarcina lutea PCI-1001-FDA. Antibiotic antibiotic to diffuse into the agar to inhibit the growth Medium No. 5 (Difco) was adjusted to pH 7.0, of S. lutea. sterilized, and maintained at 50 C until inoculated. Zones of inhibition were observed surrounding Overnight growth of S. lutea on a Trypticase Soy discs from the control tube and those dilutions of EP Agar slant was suspended by washing with pH 7.0 in which there was insufficient enzyme to degrade the phosphate buffer (1% solution of Harleco Na+, antibiotic. The highest dilution of EP that prevented K+ phosphate salts, pH 7.0). The suspension was formation of a zone of inhibition was used to calculate adjusted to 80% light transmittance at 660 nm in a potency of the enzyme preparation. For example, if Coleman Jr. spectrophotometer. A 1.25-ml volume 0.1 ml of a 1:64 dilution of EP degraded the 2.5 lAg of the S. lutea suspension was added to 100 ml of the of cephalothin added to the tube, then 0.1 ml of melted agar. Plates containing 6 ml of the seeded agar undiluted EP would be expected to degrade 160 ,ug were prepared and stored at 4 C for as long as 5 days.
of the antibiotic.
The addition of 2 ml from an overnight Trypticase Preparation of assay plates. Disc-plate assays of Soy Broth culture to 100 ml of melted agar was found aminoglycosidic antibiotics were performed against to be an acceptable alternate procedure.
Bacillus subtilis ATCC 6633 obtained commerically Assay procedures. Antibiotic assay procedures of (Difco) as a spore suspension. Antiobiotic Medium Grove and Randall (2) were modified as described.
No. 5 (Difco) in 100-ml volumes was prepared, ad-Aminoglycosidic or polymyxin antibiotics were disjusted to pH 8.0, sterilized, and maintained in a liquid solved in pH 8.0 phosphate buffer (1% solution of state at 50 C. The melted agar was inoculated by the Harleco Na+, K+ phosphate salts, pH 8.0) to contain addition of 0.25 ml of the B. subtilis spore suspension. 1,000 ,g/ml. Standard curves were prepared in a Volumes (6 ml) of the inoculated agar were pipetted mixture of 25% Trypticase Soy Broth and 75% to 9-cm plastic petri plates. The agar plates were pooled normal human serum so that the diluent for allowed to solidify and were stored at 4 C for as long the standard curves was similar to the constituents in as 5 days.
the specimens after EP was added. Each lot of serum Colistin and polymyxin B were assayed against used was free from antibacterial activity by itself The Bordetella bronchiseptica ATCC 4617. A 1-ml amount solution concentrations for preparation of the from an overnight Trypticase Soy Broth culture (109 reference curves for gentamicin, kanamycin, cells/ml) of the assay organism was added to 100 ml nebramycin (factor 6), and streptomycin were 20, 10, Samples in human sera were prepared to contain 10 and 30 ,g of non-3-lactam antibiotics per ml, concentrations that might be found in patients receiving the antibiotics. These samples also contained a constant concentration of 50 Mg of cephalexin, cephaloridine, cephaloglycin, or cephalothin per ml. A 0.1-ml amount of EP was added to 0.3 ml of each serum specimen. A specimen of each antibiotic without the EP was prepared as a control as indicated in Table 1 . All specimens, reference solutions, and controls were incubated for 1 hr at 37 C. After incubation of the solutions, paper discs (6.3 mm in diameter) were saturated (0.02 ml) with specimen or appropriate standard and were placed on seeded agar plates in duplicate. Samples containing 30 ,ug of the non-3-lactam antibiotics per ml were diluted 1:10 in the serum mixture to be read within the linear range of the standard curve. Assay plates for the aminoglycosidic antibiotics were incubated for 6 pg/ml pAgIg/mI Ag/mI Kg/ml pg/ml pg/mI pg/mI pIg/mI pg/mj pg/ml p g/ml pUg/mi a Control specimens containing each cephalosporin alone showed no activity after incubation with enzyme preparation. 6 Specimens with no cephalosporins or enzyme preparation added were assayed for the indicated antibiotic.
c All activity due to a cephalosporin antibiotic must be removed from the specimen before attempting to assay the remaining antibiotic. Therefore, the potency of the crude enzyme preparation must be assayed to insure the destruction of the expected cephalosporin levels. A potency assay was used to predict the maximal serum levels of cephalosporin that could be destroyed by this method.
Enzyme titers achieved by the above method proved sufficient to destroy peak concentrations of cephalosporins found in the serum of patients with normal renal function, i.e., about 50 Ag/ml or less (3, 4) . Concentrations of certain cephalosporins in excess of 100 ,g/ml, as in azotemic patients (3), require special consideration. In such cases, the specimen should be appropriately diluted to bring the cephalosporin concentration into the range for enzymatic destruction. Care must be taken not to dilute the serum specimen beyond the detectable limit of the antibiotic being monitored. For instance, if the critical serum level of the monitored antibiotic were 10 u&g/ml and the lower detectable limit of the assay of that antibiotic were 0.6 ,ug/ml, a high dilution of the serum specimen may dilute a critical level (greater than 10 ,g/ml, in this case) of the antibiotic to a level not detectable by the assay. A specimen containing 20 ,ug of the monitored antibiotic per ml, if diluted 1:50, would fall below the lower limit of the assay, rendering a potentially dangerous level of the antibiotic undetected.
Determination of the cephalosporin concentration in a mixture by subtracting the individually determined aminoglycosidic or polymyxin activity from a "total activity" of the mixture is most likely an invalid procedure. Another assay method might be utilized to quantitate the cephalosporin activity in the mixture. By buffering the assay medium at a pH value outside the optimal range for the non-3-lactam antibiotic, the effect of this antibiotic on the cephalosporin assay may be minimized. However, the validity of this procedure would have to be proven before clinical application could be made.
Assay values for aminoglycosidic antibiotics may be determined within 8 hr from collection of the serum specimen. Growth characteristics of the assay organism, B. bronchiseptica, require incubation of the polymyxin or colistin assay plates for at least 16 hr, bringing the minimal time between collection of the specimen and reading the assay to about 18 hr.
This method provides a rapid clinical laboratory assay for determining serum concentrations of potentially toxic antibiotics administered in combination with cephalosporins or penicillins.
